Global HIV Self Testing Market Outlook 2027
Global HIV Self-Testing Market Analysis – 2018-2027
HIV self-testing kits are those rapid diagnostic products which is used to perform the testing of HIV in a private environment through the specimen collected from blood, oral fluid or urine of an individual. The results interpreted through these kits are highly accurate and can be compared to the diagnostics of laboratories. The global HIV self-testing market is anticipated to record a CAGR of 45.62% over the forecast period, i.e. 2020-2025. Factors such as increasing adoption of HIV self-testing kits on the back of increasing public sector funding and collaborations, growing prevalence of HIV across the world, which continues to be a burden for nations around the globe along with the opportunities observed in making HIV kits available in several nations where there are no policies for HIVST are some of the factors anticipated to promote towards the growth of the global HIV self-testing market. A statistical report titled Global AIDS Epidemic by the UNAIDS and World Health Organization (WHO), stated that nearly 770,000 people died of AIDS and around 1.7 million people were affected newly by HIV in the year 2018.
The global HIV self-testing market consists of various segments that are segmented by sample, by product technology, by test generation and by region. The test generation segment is sub-divided into 2nd, 3rd and 4th. Out of these, the 2nd generation segment, which was valued at USD 23.15 million in the year 2018 is anticipated to grow with a CAGR of 44.84% over the forecast period. The second-generation HIV self-testing kits detect the HIV-1 and HIV-2 antibodies. The window period of the second-generation kits is usually longer as compared to the third and fourth generation kits. Most of the products used for HIV self-testing belong to the second generation. The preference for the second-generation HIV self-testing kits is high owing to its lower cost when compared to third and fourth generation self-testing kits.
Based on Region, the global HIV self-testing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Latin America was valued at USD 1.87 million in the year 2018 and is anticipated to grow with a CAGR of 43.64% over the forecast period. The market is further anticipated to gain an incremental $ opportunity of USD 14.84 million in the year 2025 as compared to the previous year.
Some of the affluent industry leaders in the global HIV self-testing market are OraSure Technologies, Inc., Chembio Diagnostics, Inc., WAMA Diagnostica, ECO Diagnostica, Orange Life and Ebram Produtos Laboratoriais Ltda.
HIV self-testing kits are those rapid diagnostic products which is used to perform the testing of HIV in a private environment through the specimen collected from blood, oral fluid or urine of an individual. The results interpreted through these kits are highly accurate and can be compared to the diagnostics of laboratories. The global HIV self-testing market is anticipated to record a CAGR of 45.62% over the forecast period, i.e. 2020-2025. Factors such as increasing adoption of HIV self-testing kits on the back of increasing public sector funding and collaborations, growing prevalence of HIV across the world, which continues to be a burden for nations around the globe along with the opportunities observed in making HIV kits available in several nations where there are no policies for HIVST are some of the factors anticipated to promote towards the growth of the global HIV self-testing market. A statistical report titled Global AIDS Epidemic by the UNAIDS and World Health Organization (WHO), stated that nearly 770,000 people died of AIDS and around 1.7 million people were affected newly by HIV in the year 2018.
The global HIV self-testing market consists of various segments that are segmented by sample, by product technology, by test generation and by region. The test generation segment is sub-divided into 2nd, 3rd and 4th. Out of these, the 2nd generation segment, which was valued at USD 23.15 million in the year 2018 is anticipated to grow with a CAGR of 44.84% over the forecast period. The second-generation HIV self-testing kits detect the HIV-1 and HIV-2 antibodies. The window period of the second-generation kits is usually longer as compared to the third and fourth generation kits. Most of the products used for HIV self-testing belong to the second generation. The preference for the second-generation HIV self-testing kits is high owing to its lower cost when compared to third and fourth generation self-testing kits.
Based on Region, the global HIV self-testing market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Latin America was valued at USD 1.87 million in the year 2018 and is anticipated to grow with a CAGR of 43.64% over the forecast period. The market is further anticipated to gain an incremental $ opportunity of USD 14.84 million in the year 2025 as compared to the previous year.
Some of the affluent industry leaders in the global HIV self-testing market are OraSure Technologies, Inc., Chembio Diagnostics, Inc., WAMA Diagnostica, ECO Diagnostica, Orange Life and Ebram Produtos Laboratoriais Ltda.
Global HIV Self Testing Market
1. INTRODUCTION
MARKET DEFINITION
MARKET SEGMENTATION
PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
RESEARCH PROCESS
SECONDARY RESEARCH
PRIMARY RESEARCH
MARKET SIZE ESTIMATION
4. EXECUTIVE SUMMARY - GLOBAL HIV SELF TESTING MARKET
5. REGULATORY LANDSCAPE
6. ANALYSIS OF MARKET DYNAMICS
6.1. GROWTH DRIVERS
6.2. KEY TRENDS
7. KEY MARKET OPPORTUNITIES
8. MAJOR ROADBLOCKS FOR THE MARKET GROWTH
9. AVERAGE PRICING ANALYSIS
10. INDUSTRY RISK ANALYSIS
DEMAND RISK ANALYSIS
SUPPLY RISK ANALYSIS
11. GLOBAL HIV SELF TESTING MARKET OUTLOOK
11.1. GLOBAL MARKET SIZE AND FORECAST, 2018-2025F
MARKET ANALYSIS
BY VALUE (USD MILLION)
BY VOLUME (MILLION UNITS)
11.2. GLOBAL HIV SELF TESTING MARKET SEGMENTATION, 2018-2025F
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
11.2.1. BY REGIONS
11.2.1.1. SOUTH EAST ASIA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
MARKET OVERVIEW
MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.1.1. BY MARKET SEGMENTATION
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
BY COUNTRY
VIETNAM, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
MALAYSIA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
INDONESIA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
THAILAND, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
SINGAPORE, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
PHILIPPINES, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
11.2.1.2. LATIN AMERICA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
MARKET ANALYSIS
MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.2.1. BY MARKET SEGMENTATION
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
BY COUNTRY
BRAZIL, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
MEXICO, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
ARGENTINA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
PERU, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
VENEZUELA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
CHILE, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
CUBA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
12. COMPANY PROFILES
CHEMBIO
DETAILED OVERVIEW
ASSESSMENT OF KEY PRODUCT OFFERINGS
ANALYSIS OF GROWTH STRATEGIES
KEY COLLABORATIONS AND JOINT VENTURES
KEY MERGERS AND ACQUISITIONS
RECENT NEWS AND DEVELOPMENTS
KEY CLIENTS AND PARTNERS
EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS
ORA SURE TECHNOLOGIES
WAMA DIAGN?STICA
ECO DIAGN?STICA
ORANGE LIFE
EBRAM PRODUTOS LABORATORIAIS LTDA.
13. STRATEGIC RECOMMENDATIONS
1. INTRODUCTION
MARKET DEFINITION
MARKET SEGMENTATION
PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
RESEARCH PROCESS
SECONDARY RESEARCH
PRIMARY RESEARCH
MARKET SIZE ESTIMATION
4. EXECUTIVE SUMMARY - GLOBAL HIV SELF TESTING MARKET
5. REGULATORY LANDSCAPE
6. ANALYSIS OF MARKET DYNAMICS
6.1. GROWTH DRIVERS
6.2. KEY TRENDS
7. KEY MARKET OPPORTUNITIES
8. MAJOR ROADBLOCKS FOR THE MARKET GROWTH
9. AVERAGE PRICING ANALYSIS
10. INDUSTRY RISK ANALYSIS
DEMAND RISK ANALYSIS
SUPPLY RISK ANALYSIS
11. GLOBAL HIV SELF TESTING MARKET OUTLOOK
11.1. GLOBAL MARKET SIZE AND FORECAST, 2018-2025F
MARKET ANALYSIS
BY VALUE (USD MILLION)
BY VOLUME (MILLION UNITS)
11.2. GLOBAL HIV SELF TESTING MARKET SEGMENTATION, 2018-2025F
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
11.2.1. BY REGIONS
11.2.1.1. SOUTH EAST ASIA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
MARKET OVERVIEW
MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.1.1. BY MARKET SEGMENTATION
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
BY COUNTRY
VIETNAM, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
MALAYSIA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
INDONESIA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
THAILAND, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
SINGAPORE, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
PHILIPPINES, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
11.2.1.2. LATIN AMERICA HIV SELF TESTING MARKET, 2018-2025F (USD MILLION, MILLION UNITS)
MARKET ANALYSIS
MARKET VALUE AND VOLUME, 2018-2025F (USD MILLION, MILLION UNITS)
ASSESSMENT OF MACROECONOMIC FACTORS
11.2.1.2.1. BY MARKET SEGMENTATION
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
BY COUNTRY
BRAZIL, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
MEXICO, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
ARGENTINA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
PERU, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
VENEZUELA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
CHILE, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
CUBA, 2018-2025F (USD MILLION)
MARKET ANALYSIS
MARKET SIZE, 2018-2025F (USD MILLION)
BY SAMPLE
BLOOD, 2018-2025F (USD MILLION)
ORAL FLUID, 2018-2025F (USD MILLION)
URINE, 2018-2025F (USD MILLION)
BY PRODUCT TECHNOLOGY
LATERAL FLOW IMMUNOASSAY, 2018-2025F (USD MILLION)
IMMUNOFILTRATION, 2018-2025F (USD MILLION)
BY TEST GENERATION
2ND, 2018-2025F (USD MILLION)
3RD, 2018-2025F (USD MILLION)
4TH, 2018-2025F (USD MILLION)
12. COMPANY PROFILES
CHEMBIO
DETAILED OVERVIEW
ASSESSMENT OF KEY PRODUCT OFFERINGS
ANALYSIS OF GROWTH STRATEGIES
KEY COLLABORATIONS AND JOINT VENTURES
KEY MERGERS AND ACQUISITIONS
RECENT NEWS AND DEVELOPMENTS
KEY CLIENTS AND PARTNERS
EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS
ORA SURE TECHNOLOGIES
WAMA DIAGN?STICA
ECO DIAGN?STICA
ORANGE LIFE
EBRAM PRODUTOS LABORATORIAIS LTDA.
13. STRATEGIC RECOMMENDATIONS
